http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114259464-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c3f695830c6ddcdd8d50ad21ab26e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c27f4a786895417d03d0b1045587100
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb023780128bfa1f50021c61486f872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62aa8c5f64918a76e5cf246a929882fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_360ba13a25e0555925ee25366d2b2a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a0a9a320db360fe2e93e49e25698b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f212bddba3da02e9e7ba5aefd7e2c5e2
publicationDate 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114259464-A
titleOfInvention A kind of compound moxidectin external use drops
abstract The invention provides a compound moxidectin topical drop. The main components and their mass percentages are as follows: moxidectin: 2.2-3.5%; imidacloprid: 3.0-10.0%; azone: 1.7-5.1% ; Isopropyl myristate: 1.5-7.8%; Propylene glycol: 5.6-13.1%; Dimethyl sulfoxide: 20.0-59.0%; Antioxidant: 0.1-0.5%; the rest are solvents. For the prevention and treatment of parasitic diseases, it penetrates the skin quickly and reduces the possible damage to the skin caused by a large dose or a single transdermal agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114588108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116407501-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116407501-A
priorityDate 2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203122-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135541675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420549279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153640463

Total number of triples: 50.